Menu
Home  /  Award Management  /  Residual Balances

Award Statistics FY25

Total Awards
$2092M
Federal Awards
$1007M
Non-Federal Awards
$1085M
Research Expenditures
5th (FY24)

Residual Balances - Moving to Unrestricted Projects

Page Updated: Aug 21, 2026

Background

Fixed-price and Clinical Trial agreements are common contracting mechanisms used between the UW and external sponsors. These agreements require the UW to provide goods or services in exchange for an agreed purchase price. The actual cost of providing the agreed upon goods or services may or may not equal the agreed upon purchase price.

If the purchase price exceeds the UW's costs, a residual balance may be available. When the fixed-price or Clinical Trial project is otherwise ready for Closeout, this balance can be transferred to an unrestricted project. The transfer of these balances will occur after all project costs, including all F&A, are posted to the fixed-price or clinical trial project. The unrestricted project is to be used by the PI to further his/her research activities.

Campus Process

Additional information and Frequently Asked Questions (FAQs).

If you have questions or need guidance, please e-mail residual@rsp.wisc.edu.

Research and Sponsored Programs
University of Wisconsin - Madison
21 North Park Street, Suite 6301
Madison, Wisconsin 53715-1218
608-262-3822
608-262-5111
Privacy Notice © 2026 Board of Regents of the University of Wisconsin System
Feedback, questions or accessibility issues: eRA@rsp.wisc.edu